CORC

在结果中检索

CORC

浏览/检索结果: 共15条，第1-10条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
A Novel Allosteric Inhibitor of Phosphoglycerate Mutase 1 Suppresses Growth and Metastasis of Non-Small-Cell Lung Cancer 期刊论文
CELL METABOLISM, 2019, 卷号: 30, 期号: 6, 页码: 1107-+
作者:  Huang, Ke;  Liang, Qian;  Zhou, Ye;  Jiang, Lu-lu;  Gu, Wei-ming
收藏  |  浏览/下载：79/0  |  提交时间：2020/07/01
Blocking ROR1 enhances the roles of erlotinib in lung adenocarcinoma cell lines 期刊论文
ONCOLOGY LETTERS, 2019, 卷号: 18, 期号: 3, 页码: 2977-2984
作者:  Wang, Hui-Li;  Liu, Yan-Chun;  Long, Ming-Peng;  Zheng, Chuan;  Yang, Jia-Hui
收藏  |  浏览/下载：98/0  |  提交时间：2019/11/07
Erlotinib inhibits colon cancer metastasis through inactivation of TrkB-dependent ERK signaling pathway 期刊论文
JOURNAL OF CELLULAR BIOCHEMISTRY, 2019, 卷号: 120, 期号: 7
作者:  Li, Yunfeng;  Shen, Tao;  Cheng, Xianshuo;  Xia, Cuifeng;  Li, Qiang
收藏  |  浏览/下载：26/0  |  提交时间：2019/12/04
Erlotinib versus gemcitabine/cisplatin in Chinese patients with EGFR mutation-positive advanced non-small-cell lung cancer: Crossover extension and post-hoc analysis of the ENSURE study 期刊论文
LUNG CANCER, 2019, 卷号: 130
作者:  Wu, Yi-Long;  Zhou, Caicun;  Lu, Shun;  Qin, Shukui;  Pan, Hongming
收藏  |  浏览/下载：23/0  |  提交时间：2019/12/05
Efficacy of bevacizumab combined with erlotinib for advanced hepatocellular carcinoma: a single-arm meta-analysis based on prospective studies 期刊论文
BMC CANCER, 2019, 卷号: 19
作者:  He, Liyun;  Deng, Huan;  Lei, Jun;  Yi, Fengming;  Li, Jine
收藏  |  浏览/下载：28/0  |  提交时间：2019/11/19
Erlotinib versus gemcitabine/cisplatin in Chinese patients with EGFR mutation-positive advanced non-small-cell lung cancer: Crossover extension and post-hoc analysis of the ENSURE study 期刊论文
LUNG CANCER, 2019, 卷号: 130, 页码: 18-24
作者:  Wu, Yi-Long;  Zhou, Caicun;  Lu, Shun;  Qin, Shukui;  Pan, Hongming
收藏  |  浏览/下载：28/0  |  提交时间：2019/11/19
Cost-effectiveness of afatinib, gefitinib, erlotinib and pemetrexed-based chemotherapy as first-line treatments for advanced non-small cell lung cancer in China 期刊论文
LUNG CANCER, 2019, 卷号: 127
作者:  Gu, Xiaohua;  Zhang, Qiang;  Chu, Yun-Bo;  Zhao, Yi-Yang;  Zhang, Yan-Jun
收藏  |  浏览/下载：14/0  |  提交时间：2019/12/05
SRC and MEK Co-inhibition Synergistically Enhances the Anti-tumor Effect in Both Non-small-cell Lung Cancer (NSCLC) and Erlotinib-Resistant NSCLC 期刊论文
FRONTIERS IN ONCOLOGY, 2019, 卷号: 9
作者:  Yuan, Man;  Xu, Lin-feng;  Zhang, Juan;  Kong, Si-yuan;  Wu, Man
收藏  |  浏览/下载：9/0  |  提交时间：2019/12/05
Cost-effectiveness of afatinib, gefitinib, erlotinib and pemetrexed-based chemotherapy as first-line treatments for advanced non-small cell lung cancer in China 期刊论文
Lung Cancer, 2019, 卷号: Vol.127, 页码: 84-89
作者:  Xiaohua Gu;  Qiang Zhang;  Yun-Bo Chu;  Yi-Yang Zhao;  Yan-Jun Zhang
收藏  |  浏览/下载：1/0  |  提交时间：2019/12/13
Blocking ROR1 enhances the roles of erlotinib in lung adenocarcinoma cell lines 期刊论文
2019, 卷号: 18, 期号: 3, 页码: 2977-2984
作者:  Wang, Hui-Li[1];  Liu, Yan-Chun[2];  Long, Ming-Peng[1];  Zheng, Chuan[1];  Yang, Jia-Hui[1]
收藏  |  浏览/下载：12/0  |  提交时间：2019/12/16

©版权所有 ©2017 CSpace - Powered by CSpace